Skip to main content

Market Overview

Y-mAbs Therapeutics, Inc. (YMAB)

35.63 0.00 (0.00%)

Analyst Ratings

DateResearch FirmActionCurrentPT
3/01/21HC Wainwright & Co.MaintainsBuy70.0
1/15/21B of A SecuritiesDowngradesNeutral56.0
11/12/20Morgan StanleyMaintainsEqual-Weight45.0
11/09/20HC Wainwright & Co.MaintainsBuy65.0
7/15/20Morgan StanleyMaintainsEqual-Weight42.0
5/11/20HC Wainwright & Co.ReiteratesBuy52.0
5/05/20BarclaysInitiates Coverage OnOverweight44.0
5/01/20Janney CapitalInitiates Coverage OnBuy
1/28/20H.C. WainwrightReiteratesBuy41.0
12/24/19JP MorganInitiates Coverage OnOverweight39.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter